Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DEREK VANAMERONGEN

Allopathic & Osteopathic Physicians Obstetrics & Gynecology Gynecology

NPI
1487849584
CMS profile
339920
Location
CINCINNATI, OH

General Payments · PY2018–2024

$361,079.78

  • Reported across 242 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$69,615.75

31 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Eli Lilly and Company $25,850.00 6
Amgen Inc. $10,100.00 11
Medtronic, Inc. $9,380.00 1
PFIZER INC. $6,835.72 5
Novo Nordisk AS $5,400.00 2
Lilly USA, LLC $4,400.00 1
CHIESI USA, INC. $3,000.00 1
Johnson & Johnson Health Care Systems Inc. $1,875.00 1
CLINIGEN, INC. $1,399.62 2
Salix Pharmaceuticals, a division of Bausch Health US, LLC $1,375.41 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $59,139.87 59
PY2019 $38,281.38 39
PY2020 $46,312.48 54
PY2021 $60,279.50 23
PY2022 $49,038.91 24
PY2023 $38,411.89 12
PY2024 $69,615.75 31

Payment records · PY2024 (31)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $173.75 05/03/2024 Travel and Lodging Undisputed 01/23/2026 1117707504 CMS
Amgen Inc. $276.74 05/03/2024 Food and Beverage Undisputed 01/23/2026 1117707506 CMS
Amgen Inc. $80.91 05/03/2024 Travel and Lodging Undisputed 01/23/2026 1117707508 CMS
Amgen Inc. $173.75 05/03/2024 Travel and Lodging Undisputed 01/23/2026 1117707516 CMS
Amgen Inc. $149.38 05/03/2024 Food and Beverage Undisputed 01/23/2026 1117707518 CMS
Amgen Inc. $173.75 05/03/2024 Travel and Lodging Undisputed 01/23/2026 1117707520 CMS
Amgen Inc. $294.98 05/03/2024 Travel and Lodging Undisputed 01/23/2026 1117707522 CMS
Amgen Inc. $276.74 05/03/2024 Food and Beverage Undisputed 01/23/2026 1117707524 CMS
Amgen Inc. $1,500.00 05/21/2024 Consulting Fee Undisputed 01/23/2026 1117707510 CMS
Amgen Inc. $3,500.00 05/21/2024 Consulting Fee Undisputed 01/23/2026 1117707514 CMS
Amgen Inc. $3,500.00 05/22/2024 Consulting Fee Undisputed 01/23/2026 1117707512 CMS
Chiesi USA, Inc. $3,000.00 01/04/2024 Honoraria Undisputed 01/23/2026 1151823584 CMS
Clinigen, Inc. $1,199.62 07/12/2024 Consulting Fee Undisputed 01/23/2026 1071129708 CMS
Clinigen, Inc. $200.00 11/15/2024 Honoraria Undisputed 01/23/2026 1071129712 CMS
Eli Lilly and Company $5,500.00 02/08/2024 Consulting Fee Undisputed 01/23/2026 1136150213 CMS
Eli Lilly and Company $4,400.00 03/25/2024 Consulting Fee Undisputed 01/23/2026 1136155272 CMS
Eli Lilly and Company $4,400.00 05/22/2024 Consulting Fee Undisputed 01/23/2026 1136141955 CMS
Eli Lilly and Company $2,750.00 07/05/2024 Consulting Fee Undisputed 01/23/2026 1136143509 CMS
Eli Lilly and Company $4,400.00 09/18/2024 Consulting Fee Undisputed 01/23/2026 1136150215 CMS
Eli Lilly and Company $4,400.00 12/09/2024 Consulting Fee Undisputed 01/23/2026 1136141953 CMS
Johnson & Johnson Health Care Systems Inc. $1,875.00 02/29/2024 Consulting Fee Undisputed 01/23/2026 1077573080 CMS
Lilly USA, LLC $4,400.00 11/22/2024 Consulting Fee Undisputed 01/23/2026 1136150217 CMS
Medtronic, Inc. $9,380.00 12/10/2024 Consulting Fee Undisputed 01/23/2026 1112050839 CMS
Novo Nordisk AS $3,600.00 06/18/2024 Consulting Fee Undisputed 01/23/2026 1096552025 CMS
Novo Nordisk AS $1,800.00 06/18/2024 Consulting Fee Undisputed 01/23/2026 1096553441 CMS
PFIZER INC. $646.30 11/13/2024 Travel and Lodging Undisputed 01/23/2026 1131588071 CMS
PFIZER INC. $1,042.55 11/13/2024 Travel and Lodging Undisputed 01/23/2026 1131588075 CMS
PFIZER INC. $530.21 11/13/2024 Travel and Lodging Undisputed 01/23/2026 1131588079 CMS
PFIZER INC. $66.66 11/13/2024 Food and Beverage Undisputed 01/23/2026 1131588083 CMS
PFIZER INC. $4,550.00 12/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1131238495 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $1,375.41 04/29/2024 Travel and Lodging Undisputed 01/23/2026 1153707695 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.